Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
HG

Harry E. Gruber — 47 Patents

TOTocagen: 10 patents #2 of 11Top 20%
CHChiron: 7 patents #77 of 583Top 15%
GPGensia Pharmaceuticals: 7 patents #1 of 16Top 7%
University of California: 6 patents #1,311 of 18,278Top 8%
DBDenovo Biopharma: 3 patents #2 of 13Top 20%
INIntervu: 2 patents #2 of 6Top 35%
GEGensia: 2 patents #6 of 19Top 35%
MTMetabasis Therapeutics: 1 patents #48 of 71Top 70%
ATAkamai Technologies: 1 patents #315 of 429Top 75%
CVChiron Viagene: 1 patents #7 of 18Top 40%
Rancho Santa Fe, CA: #21 of 335 inventorsTop 7%
California: #8,880 of 386,348 inventorsTop 3%
Overall (All Time): #59,703 of 4,157,543Top 2%
47 Patents All Time
Harry E. Gruber has been granted 47 US patents while listed as an inventor at Tocagen. The first was granted in 1990 and the most recent in January 2022. Harry E. Gruber ranks #59,703 of 4,157,543 US inventors in our database (top 1.4%). Patent records list Harry E. Gruber in Rancho Santa Fe, CA, US.

Issued Patents All Time

Showing 1–25 of 47 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11230719 Retroviral vector having immune-stimulating activity Douglas J. Jolly, Amy H. Lin, Joan M. Robbins, Derek G. Ostertag 2022-01-25
11191764 Formulations of 5-fluorocytosine and uses thereof Douglas J. Jolly, Kay Olmstead 2021-12-07
11065311 Retroviral vector with mini-promoter cassette Douglas J. Jolly, Amy H. Lin, Christopher R. Logg, Noriyuki Kasahara 2021-07-20
10449194 Formulations of 5-fluorocytosine and uses thereof Douglas J. Jolly, Kay Olmstead 2019-10-22 $435,000
10407666 Recombinant vectors Douglas J. Jolly, Omar D. Perez, Christopher R. Logg 2019-09-10 $1,084,000
10035983 Gene therapy vectors and cytosine deaminases Douglas J. Jolly, Omar D. Perez, Christopher R. Logg 2018-07-31 $2,225,000
9889133 Formulations of 5-fluorocytosine and uses thereof Douglas J. Jolly, Kay Olmstead 2018-02-13 $3,283,000
9732326 Recombinant vectors Douglas J. Jolly, Omar D. Perez, Christopher R. Logg 2017-08-15 $3,099,000
9669049 Compositions comprising gamma retrovirus vectors and methods of treating proliferative disorders Douglas J. Jolly, Derek G. Ostertag, Ryan Burnett, Amy H. Lin, Tiffany Huang +1 more 2017-06-06 $4,254,000
9642921 Cancer combination therapy and recombinant vectors Joan M. Robbins, Douglas J. Jolly, Derek G. Ostertag, Tiffany Huang 2017-05-09
9320738 Formulations of 5-fluorocytosine and uses thereof Douglas J. Jolly, Kay Olmstead 2016-04-26
8829173 Recombinant vectors Douglas J. Jolly, Omar D. Perez, Christopher R. Logg 2014-09-09
8722867 Gene therapy vectors and cytosine deaminases Douglas J. Jolly, Omar D. Perez, Christopher R. Logg 2014-05-13
7120387 Mission certification quiz for fundraising campaign Ephraim Feig, Julie Schwartz 2006-10-10 $817,000
6847799 Mission certification quiz for fundraising campaign Ephraim Feig, Julie Schwartz 2005-01-25 $3,719,000
6603955 Mission certification quiz for fundraising campaign Ephraim Feig, Julie Schwartz 2003-08-05
6569679 Producer cell that generates adenoviral vectors encoding a cytokine and a conditionally lethal gene Jack R. Barber, Douglas J. Jolly 2003-05-27 $26,743,000
6531307 Adenoviral vectors encoding a cytokine and a conditionally lethal gene Jack R. Barber, Douglas J. Jolly 2003-03-11 $24,720,000
6496856 Video storage and retrieval system Brian Kenner 2002-12-17 $4,989,000
6495349 Chimeric gene constructs Douglas J. Jolly, James G. Respess, Paul K. Laikind 2002-12-17
6410326 Method for inhibiting human tumor cells Douglas J. Jolly, James G. Respess, Paul K. Laikind, Jack R. Barber, Daniel C. St. Louis +3 more 2002-06-25 $14,782,000
6269394 System and method for delivery of video data over a computer network Brian Kenner 2001-07-31
6241982 Method for treating brain cancer with a conditionally lethal gene Jack R. Barber, Douglas J. Jolly 2001-06-05 $46,215,000
6181867 Video storage and retrieval system Brian Kenner 2001-01-30
6133029 Replication defective viral vectors for infecting human cells Douglas J. Jolly, James G. Respess, Paul K. Laikind 2000-10-17 $175,808,000